OrbiMed Capital GP VI, Director: Turnstone Biologics TSBX Buy · Filed 23/07/24

Trade details

Type: Insider buy
Amount: $4,999,992
Shares · price: 416,666 sh · $12.00 a share
Held after: 3,099,265 sh
Stock: Turnstone Biologics TSBX
Person: OrbiMed Capital GP VIDirector
Trade date: 23/07/20
Filed: 23/07/24
Days to filing: 4 days

14 insiders bought this week

Insiders buying this week: 14 insiders
Holding change: +15.5%

Turnstone Biologics trades, last 26 weeks

What else happened in Turnstone Biologics around then

Filed or reported within 30 days of the trade day · 23/06/20~23/08/19

OrbiMed Capital GP VI's recent trades

OrbiMed Capital GP VIDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
OrbiMed Capital GP VIDirector
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
OrbiMed Capital GP VI10% Owner
SellAdicet Bio
Sell
Adicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07